Lipids & metabolic liver disease

Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

Elevated baseline TyG index and TG/HDL-C ratio were associated with a higher risk of CVD after adjustment for the well-established CVD risk factors. These associations were largely mediated by greater prevalence of dyslipidemia, type 2 diabetes, and hypertension.

Study context

Population
UK Biobank participants with triglyceride-glucose (TyG) index and TG/HDL-C ratio data, free from cardiovascular disease (CVD) at baseline
Participants
403,335 participants
Exposure
Higher quartiles vs lowest quartile of TyG index and TG/HDL-C ratio
Outcome
Incident total CVD
Follow-up
Median 8.1 years
Methodological detailsUK Biobank, multivariable-adjusted Cox models, mediation analyses
  • UK Biobank
  • Multivariable-adjusted Cox models
  • Mediation analyses

Main finding

As reported in the abstract

Total CVD

Multivariable-adjusted HR

TyG Q2 vs TyG Q1
1.05
TyG Q3 vs TyG Q1
1.05
TyG Q4 vs TyG Q1
1.19
TG/HDL-C Q2 vs TG/HDL-C Q1
1.07
TG/HDL-C Q3 vs TG/HDL-C Q1
1.13
TG/HDL-C Q4 vs TG/HDL-C Q1
1.29
Incident CVD overall
19,754 (4.9%)

Observational data: associations, not effects.

Further findings

CHD and stroke cases · median follow-up 8.1 years

CHD
16,404 (4.1%)
Stroke
3976 (1.0%)

Mediation of TyG index–CVD association

Dyslipidemia
45.8%
T2D
27.0%
Hypertension
15.0%

Mediation of TG/HDL-C ratio–CVD association

Dyslipidemia
40.0%
T2D
11.8%
Hypertension
13.3%

Original publication

Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol. Published 16 February 2023. doi:10.1186/s12933-023-01762-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.